||Gabriel ADEYEMO [ profile ]
M2012 Abstract and Scholarship Deadline is THREE WEEKS AWAY!
Oct 25th, 2011 - 04:28:34
*Abstract and Scholarships Deadline is ONLY THREE WEEKS AWAY!*
*Abstract Submission and Scholarship Applications*
The deadline for abstract submission and scholarship applications is *Thursday
17 November, 2011*.
Do you have a presentation in mind?
read the abstract submission guidelines and submit your abstract.
Do you need assistance to attend M2012?
http://www.microbicides2012.org/default2.asp?active_page_id=208 to find out
how to apply for scholarships, in four categories that each have distinct
3. Government Official/ Public Health Policy
*Update on the M2012 program
We are hard at work on the M2012 program. We have confirmed nine
international leaders in HIV prevention as plenary speakers, and are
planning a range of symposia, debates and roundtables to educate and
challenge participants. Plenary speakers include: Dr Connie Celum, Dr
Peter Cherutich, Dr Carl Dieffenbach, Professor Richard Hayes, Dr Betsy
Herold, Dr Frits van Griensven, Ms Milly Katana, Dr Joseph Romano and Dr
*Read the M2012 newsletter to find out whats going on
To find out more about the program, the speakers, the conference location,
the committees and much more please click here and read the first edition of
the M2012 newsletter.
For all the information you need about M2012 please visit the conference
if you require any additional information please contact the conference
secretariat on +61 2 8204 0770 or email us at info (at) microbicides2012.org
Best of luck in your application
Yours' in Prevention Science
Regional Focal Point - West Africa
Global Youth Coalition on HIV/AID (GYCA)
+234-80-6798-7317 | gabriel (at) gyca.org
www.gyca.org | www.tigweb.org
GYCA is a youth-led global network of over 6,000 young leaders and adult
allies working on youth and HIV/AIDS in 173 countries world-wide. GYCA's
mission is to empower young leaders with the skills, knowledge, resources
and opportunities they need to scale up HIV/AIDS interventions amongst their
Universal Access is possible; *
*Zero new HIV infections. **Zero discrimination and ***Zero AIDS-related